tiprankstipranks
Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
US Market
RYTM
Rhythm Pharmaceuticals
RESEARCH TOOLSreports
Want to see RYTM full AI Analyst Report?

Rhythm Pharmaceuticals (RYTM) Income Statement

608 Followers

Rhythm Pharmaceuticals Income Statement

Last quarter (Q4 2025), Rhythm Pharmaceuticals's total revenue was $57.25M, an increase of 36.87% from the same quarter last year. In Q4, Rhythm Pharmaceuticals's net income was $-47.51M. See Rhythm Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 189.76M$ 130.13M$ 77.43M$ 23.64M$ 3.15M
Gross Profit
$ 170.26M$ 116.76M$ 68.13M$ 21.50M$ 2.56M
Operating Expenses
$ 362.28M$ 382.26M$ 252.48M$ 200.66M$ 172.61M
Depreciation and Amortization
$ 1.34M$ 1.56M$ 1.76M$ 1.67M$ 1.16M
EBITDA
$ -174.12M$ -238.09M$ -168.46M$ -174.25M$ -68.45M
Operating Income
$ -192.02M$ -265.50M$ -184.36M$ -179.16M$ -170.06M
Other Income/Expenses
$ -4.03M$ 5.25M$ 243.00K$ -1.96M$ 100.45M
Pretax Income
$ -196.04M$ -260.26M$ -184.11M$ -181.12M$ -69.61M
Net Income
$ -196.54M$ -260.60M$ -184.68M$ -181.12M$ -69.61M
Per Share Metrics
Basic EPS
$ -3.11$ -4.34$ -3.20$ -3.51$ -1.37
Diluted EPS
$ -3.11$ -4.34$ -3.20$ -3.51$ -1.37
Weighted Average Shares Outstanding
 64.98M 60.99M 57.67M 52.12M 49.60M
Weighted Average Shares Outstanding (Diluted)
 64.98M 60.99M 57.67M 52.12M 49.60M
Currency in USD

Rhythm Pharmaceuticals Earnings and Revenue History